Evidence map›Paper›PMID 42340382›Full record

ArticleCellular and molecular life sciences : CMLS2026

Physical interaction with Ephrin B1 promotes CXCR4 intracellular localization and oncogenic potential.

Alessandro Rabbito, Omolade Otun, Amos Fumagalli, Ana Alonso Bartolomé, Sonya Galant, Martial Séveno, Manuel Counson, Thierry Durroux, Cherine Bechara, Martine J Smit and 5 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alessandro RabbitoIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France.
Omolade OtunIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France.
Amos FumagalliIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France.
Ana Alonso BartoloméImmuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg, Luxembourg.
Sonya GalantIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France.
Martial SévenoBCM, Univ Montpellier, CNRS, INSERM, Montpellier, France.
Manuel CounsonImmuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg, Luxembourg.
Thierry DurrouxIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France.
Cherine BecharaIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France.
Martine J SmitDepartment of Chemistry and Pharmaceutical Sciences, Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Sébastien GranierIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France.
Martyna SzpakowskaImmuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg, Luxembourg.
Andy ChevignéImmuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg, Luxembourg.
Séverine Chaumont-DubelIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France. severine.chaumont-dubel@igf.cnrs.fr.
Philippe MarinIGF, Univ Montpellier, CNRS, INSERM, 141 rue de la Cardonille, Montpellier, 34094, France. philippe.marin@igf.cnrs.fr.ORCID http://orcid.org/0000-0002-5977-7274

Funding

FP7 People: Marie-Curie Actions FP7 People: Marie-Curie Actions
6 · The paper itself

Abstract

Chemokine receptor 4 (CXCR4) is a member of the chemokine receptor family, exclusively activated by the chemokine CXCL12. While CXCR4 regulates numerous physiological processes associated with cell migration and embryogenesis, its overexpression has been involved in various cancer types. Studies suggest that intracellular CXCR4 rather than CXCL12-induced signaling at the plasma membrane contributes to its pro-tumorigenic functions. Given the role of GPCR-interacting proteins in their trafficking and subcellular localization, we characterized the CXCR4 interactome using an affinity purification coupled to mass spectrometry (AP-MS) strategy. The most abundant protein identified in the CXCR4 interactome is Ephrin B1, a member of the Ephrin protein family that shares several functions with CXCR4, such as the regulation of cell migration and proliferation. Further studies showed that the interaction between CXCR4 and Ephrin B1 is direct and enhanced upon CXCR4 activation by CXCL12. They also indicated that Ephrin B1 prevents CXCR4 N-glycosylation, decreases CXCR4 cell surface expression, and consistently inhibits CXCL12-induced CXCR4 coupling to G

Indexed as

CarcinogenesisEphrin-B1Receptors, CXCR4AnimalsCell Line, TumorCell MovementChemokine CXCL12GlycosylationHEK293 CellsHumansProtein BindingProtein TransportSignal TransductionChemokine CXCL12CXCR4 protein, humanEphrin-B1Receptors, CXCR4CancerChemokineEphrinG protein-coupled receptorInteractomeSignal transduction

Identifiers

PMID42340382
PMCPMC13572348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.